Rafferty Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.56M Buy
42,332
+38,833
+1,110% +$2.73M 0.01% 535
2026
Q2
$244K Buy
+3,499
New +$256K ﹤0.01% 1056
2023
Q1
– Sell
-929
Closed -$31.5K – 1159
2022
Q4
$31.5K Sell
929
-1,312
-59% -$63.5K ﹤0.01% 1117
2022
Q3
$108K Sell
2,241
-2,519
-53% -$150K ﹤0.01% 1121
2022
Q2
$271K Buy
4,760
+3,202
+206% +$202K ﹤0.01% 944
2022
Q1
$126K Sell
1,558
-58
-4% -$8.58K ﹤0.01% 1161
2021
Q4
$327K Buy
1,616
+512
+46% +$111K ﹤0.01% 1136
2021
Q3
$298K Buy
1,104
+371
+51% +$89.2K ﹤0.01% 1129
2021
Q2
$189K Buy
+733
New +$203K ﹤0.01% 1233
2021
Q1
– Sell
-1,113
Closed -$284K – 1168
2020
Q4
$284K Buy
+1,113
New +$288K ﹤0.01% 835
2020
Q3
– Sell
-1,222
Closed -$424K – 1015
2020
Q2
$424K Buy
+1,222
New +$381K 0.01% 748
2020
Q1
– Sell
-1,277
Closed -$413K – 740
2019
Q4
$413K Sell
1,277
-418
-25% -$121K 0.01% 721
2019
Q3
$463K Buy
+1,695
New +$622K 0.01% 675

Other funds holding NKTR

Rafferty Asset Management's NKTR Position: Q3 2026 in Review

Rafferty Asset Management increased its Nektar Therapeutics (NKTR) stake by 1,110% in Q3 2026, buying an estimated $2.73M and bringing the position to 42,332 shares worth $2.56M. The position accounts for 0.01% of the portfolio, ranked #535.

Rafferty Asset Management first reported a position in NKTR in Q3 2019 and has held it in 13 quarters since. 243 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.

  • Rafferty Asset Management held 42,332 shares of Nektar Therapeutics worth $2.56M as of Q3 2026.
  • Rafferty Asset Management bought 38,833 Nektar Therapeutics shares in Q3 2026, an estimated $2.73M.
  • Nektar Therapeutics made up 0.01% of Rafferty Asset Management's portfolio in Q3 2026, its #535 holding.
  • Rafferty Asset Management first reported a position in Nektar Therapeutics in Q3 2019 and has held it in 13 quarters since.
  • 243 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.

Based on Rafferty Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.